Wednesday, January 23, 2019
Redactor's Choice
You are here: Home / Categories / Health & Beauty (page 10)

Health & Beauty

Orthopedic Surgeon Frisco For Knee Pain


 If you are looking for an orthopedic surgeon to find relief from your knee pain, consider OrthoTexas, Frisco. The group of leading surgeons and doctors specialize in treating a wide range of medical conditions to help the patients lead a pain-free life. The orthopedic surgeons at OrthoTexas, Frisco use advanced techniques to diagnose the underlying cause of the condition and provide effective treatment. They have extensive experience in treating various conditions such as ACL injury, Knee Arthritis, Torn Meniscus, Osteoarthritis, Plica Syndro... Read More »

Installation initiated for Elekta’s high-field MR-adaptive linear accelerator at Froedtert & the Medical College of Wisconsin Clinical Cancer Center


The Clinical Cancer Center, part of the Froedtert & MCW Cancer Network, is the second U.S. and fifth global site to install the MR-linac system, which is already under functional evaluation at The Netherlands Cancer Institute; University Medical Center Utrecht, the Netherlands; The University of Texas MD Anderson Cancer Center, Houston Texas; and the Institute of Cancer Research, working with its clinical partner The Royal Marsden NHS Foundation Trust in London. In 2013, the Froedtert & MCW Cancer Network join... Read More »

Kellogg Company Voluntarily Recalls Limited Number of Kellogg’s® Eggo® Nutri-Grain® Whole Wheat Waffles Due to Potential Health Risk

Kellogg logo

Listeria monocytogenes can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women. The company has received no reports of illness to date but is taking this action as part of its commitment to the health and safety of the people who eat its fo... Read More »

Merck and Pfizer Announce Investigational Ertugliflozin Met Primary Endpoint of A1C Reduction When Added to Sitagliptin and Metformin in People with Type 2 Diabetes


Merck and Pfizer plan to submit New Drug Applications to the U.S. Food and Drug Administration for ertugliflozin and two fixed-dose combinations (ertugliflozin plus JANUVIA® (sitagliptin) and ertugliflozin plus metformin) by the end of 2016, with additional regulatory submissions outside of the U.S. to follow in 2017. “It is encouraging to see further data from the VERTIS clinical development program in support of combining ertugliflozin, an SGLT2 inhibitor, with the DPP-4 inhibitor sitagliptin, which was first approved 10 years ago,” said P... Read More »

Philips introduces next generation interventional oncology solution OncoSuite* for advanced tumor analysis and therapy in Europe


“While OncoSuite can be used for a number of different cancers including bone, kidney and lung, the solution and its specific tools have been optimized for the treatment of patients with liver cancer,” said Dr Jeff Geschwind, Chairman and Chief of the Department of Radiology and Biomedical Imaging at the Yale School of Medicine. “Given the steady increase in the prevalence of non-alcoholic fatty liver disease and liver cancer [2], the development and availability of new technology is much needed to provide interventional oncologists with a brea... Read More »

Xerox Services Recognized by HfS for Excellence in Population Health Management and Care Management-as-a-Service


Xerox has a long history with population health management. The company’s government healthcare division has been enabling population health management programs, driving down costs and improving outcomes in state and local health departments for 30 years. The report recognizes Xerox for its refreshed, targeted solutions and evidence-based approach that address the needs of healthcare organizations today. Recent offerings like Xerox's Health Outcome Solutions bolstered the company’s positioning, according to HfS. The solution offers a customi... Read More »

Unilever named as an industry leader in Dow Jones Sustainability Index


Unilever achieved an overall score of 92 out of a possible 100. Unilever led the industry in 14 out of the 22 Personal Products criteria, including: Corporate Governance; Brand Management; Materiality; Supply Chain Management; Packaging; Labour Practices Indicators & Human Rights; and Corporate Citizenship & Philanthropy. 2016 is the first year Unilever has been included in Household and Personal Products as this is where Unilever now sits in MSCI and S&P’s Global Industry Classification Standard. Previously Unilever was in th... Read More »

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference


To listen to the webcast, visit our web site at and click on the “2016 Wells Fargo Healthcare Conference” link in the For Investors section located on the lower right-hand corner of that page. Information on accessing and pre-registering for the webcast will be available at beginning today. Visitors will be able to listen to an archived copy of the webcast at Contact: Media: Joan Campion, 212-733-2798 or Investors: Ryan Crowe, 212-733-8160 ... Read More »

Pfizer To Acquire Small Molecule Anti-Infective Business From AstraZeneca


Under the terms of the agreement, Pfizer will make an upfront payment of $550 million to AstraZeneca upon the close of the transaction and a deferred payment of $175 million in January 2019. In addition, AstraZeneca is eligible to receive up to $250 million in milestone payments, up to $600 million in sales-related payments, as well as tiered royalties on sales of Zavicefta and ATM-AVI in certain markets. “As we continue to reshape our Essential Health portfolio, we are focusing on areas that further address global public health needs and th... Read More »



Commenting on the figures, Mr Jean-Paul Agon, Chairman and Chief Executive Officer of L'Oréal, said: "At the end of June, the Group is confirming its growth momentum, with an increase in sales across all Divisions and all geographic Zones. As announced, the Consumer Products Division is accelerating and outperforming its market, driven by its conquest initiatives in make-up and haircare. L'Oréal Luxe, in a market that remains solid, is continuing to deliver sustained growth by capitalising on its unique brand portfolio and by maintaining... Read More »

Scroll To Top